Drugs / IBD0333
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06292208 | Mar 2024 → Dec 2029 expected | — | SUNHO（China）BioPharmaceutical CO., Ltd. | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IBD0333 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06292208 ↗ |